Microbix Biosystems Inc. (TSE:MBX – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$0.35 and traded as low as C$0.33. Microbix Biosystems shares last traded at C$0.33, with a volume of 60,286 shares changing hands.
Microbix Biosystems Price Performance
The company has a quick ratio of 5.57, a current ratio of 8.53 and a debt-to-equity ratio of 24.53. The firm has a fifty day moving average price of C$0.32 and a two-hundred day moving average price of C$0.35. The stock has a market capitalization of C$45.35 million, a P/E ratio of 11.00 and a beta of 0.25.
Microbix Biosystems Company Profile
Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.
Featured Stories
- Five stocks we like better than Microbix Biosystems
- Pros And Cons Of Monthly Dividend Stocks
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- How to Calculate Return on Investment (ROI)
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Industrial Products Stocks Investing
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.